Literature DB >> 34890966

A Commentary on: Long-term outcomes of induction chemotherapy followed by intensity modulated radiotherapy and adjuvant chemotherapy in nasopharyngeal carcinoma patients with N3 disease.

Firas Baidoun1, Abdalla Reda Mahmoud2, Mohamed Gomaa Kamel3.   

Abstract

Entities:  

Keywords:  Chemotherapy; Nasopharyngeal carcinoma; Radiotherapy

Year:  2021        PMID： 34890966      PMCID： PMC8661705          DOI： 10.1016/j.tranon.2021.101278

Source DB:  PubMed          Journal:  Transl Oncol        ISSN： 1936-5233            Impact factor:   4.243


× No keyword cloud information.
  9 in total

1.  Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

Authors:  M Al-Sarraf; M LeBlanc; P G Giri; K K Fu; J Cooper; T Vuong; A A Forastiere; G Adams; W A Sakr; D E Schuller; J F Ensley
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

2.  A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma.

Authors:  Gang Peng; Tao Wang; Kun-Yu Yang; Sheng Zhang; Tao Zhang; Qin Li; Jun Han; Gang Wu
Journal:  Radiother Oncol       Date:  2012-09-17       Impact factor: 6.280

3.  Treatment outcomes of induction chemotherapy combined with intensity-modulated radiotherapy and adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma in Southeast China.

Authors:  Peirong Wang; Feng Dong; Chuanshu Cai; Chunlin Ke
Journal:  Medicine (Baltimore)       Date:  2021-08-20       Impact factor: 1.817

4.  Influence of tumor necrosis on treatment sensitivity and long-term survival in nasopharyngeal carcinoma.

Authors:  Shao-Bo Liang; Lu-Si Chen; Xing-Li Yang; Dan-Ming Chen; Dong-Hui Wang; Chun-Yan Cui; Chuan-Bo Xie; Li-Zhi Liu; Xiang-Ying Xu
Journal:  Radiother Oncol       Date:  2020-11-18       Impact factor: 6.280

Review 5.  Nasopharyngeal carcinoma.

Authors:  Melvin L K Chua; Joseph T S Wee; Edwin P Hui; Anthony T C Chan
Journal:  Lancet       Date:  2015-08-28       Impact factor: 79.321

Review 6.  The emerging data on choice of optimal therapy for locally advanced nasopharyngeal carcinoma.

Authors:  Edwin Pun Hui; Brigette B Y Ma; Anthony T C Chan
Journal:  Curr Opin Oncol       Date:  2020-05       Impact factor: 3.645

7.  Comparison Long-term Outcome of Definitive Radiotherapy plus Different Chemotherapy Schedules in Patients with Advanced Nasopharyngeal Carcinoma.

Authors:  Yi-Chun Liu; Wen-Yi Wang; Chih-Wen Twu; Rong-San Jiang; Kai-Li Liang; Po-Ju Lin; Jing-Wei Lin; Jin-Ching Lin
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

8.  Prognostic value of tumor burden in nasopharyngeal carcinoma.

Authors:  Chuanben Chen; Zhaodong Fei; Chaoxiong Huang; Jianming Ding; Lisha Chen
Journal:  Cancer Manag Res       Date:  2018-09-03       Impact factor: 3.989
  9 in total
  1 in total

1.  Effects of CIK Cell Therapy Combined with Camrelizumab on the Quality of Life in Patients with Nasopharyngeal Carcinoma and Analysis of Prognostic Factors.

Authors:  Tao Feng; Xiu Luo; Wenping Cao; Rongjun Man; Xinrong Feng; Yujie Song
Journal:  Comput Intell Neurosci       Date:  2022-05-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.